297 related articles for article (PubMed ID: 22242859)
1. Development of FXR, PXR and CAR agonists and antagonists for treatment of liver disorders.
Fiorucci S; Zampella A; Distrutti E
Curr Top Med Chem; 2012; 12(6):605-24. PubMed ID: 22242859
[TBL] [Abstract][Full Text] [Related]
2. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
[TBL] [Abstract][Full Text] [Related]
3. Marine sponge steroids as nuclear receptor ligands.
Fiorucci S; Distrutti E; Bifulco G; D'Auria MV; Zampella A
Trends Pharmacol Sci; 2012 Nov; 33(11):591-601. PubMed ID: 23000093
[TBL] [Abstract][Full Text] [Related]
4. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor: from medicinal chemistry to clinical applications.
Fiorucci S; Mencarelli A; Distrutti E; Zampella A
Future Med Chem; 2012 May; 4(7):877-91. PubMed ID: 22571613
[TBL] [Abstract][Full Text] [Related]
6. The decrease in farnesoid X receptor, pregnane X receptor and constitutive androstane receptor in the liver after intestinal ischemia-reperfusion.
Ogura J; Terada Y; Tsujimoto T; Koizumi T; Kuwayama K; Maruyama H; Fujikawa A; Takaya A; Kobayashi M; Itagaki S; Takahashi N; Hirano T; Yamaguchi H; Iseki K
J Pharm Pharm Sci; 2012; 15(5):616-31. PubMed ID: 23331901
[TBL] [Abstract][Full Text] [Related]
7. Farnesoid X receptor agonists in biliary tract disease.
Fiorucci S; Baldelli F
Curr Opin Gastroenterol; 2009 May; 25(3):252-9. PubMed ID: 19300246
[TBL] [Abstract][Full Text] [Related]
8. FXR and PXR: potential therapeutic targets in cholestasis.
Jonker JW; Liddle C; Downes M
J Steroid Biochem Mol Biol; 2012 Jul; 130(3-5):147-58. PubMed ID: 21801835
[TBL] [Abstract][Full Text] [Related]
9. Pregnane X receptor is a target of farnesoid X receptor.
Jung D; Mangelsdorf DJ; Meyer UA
J Biol Chem; 2006 Jul; 281(28):19081-91. PubMed ID: 16682417
[TBL] [Abstract][Full Text] [Related]
10. Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR).
Chang TK; Waxman DJ
Drug Metab Rev; 2006; 38(1-2):51-73. PubMed ID: 16684648
[TBL] [Abstract][Full Text] [Related]
11. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
[TBL] [Abstract][Full Text] [Related]
12. Chemistry and Pharmacology of GPBAR1 and FXR Selective Agonists, Dual Agonists, and Antagonists.
De Marino S; Festa C; Sepe V; Zampella A
Handb Exp Pharmacol; 2019; 256():137-165. PubMed ID: 31201554
[TBL] [Abstract][Full Text] [Related]
13. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
[TBL] [Abstract][Full Text] [Related]
14. Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders.
Fiorucci S; Sepe V; Biagioli M; Fiorillo B; Rapacciuolo P; Distrutti E; Zampella A
Biochem Pharmacol; 2023 Oct; 216():115776. PubMed ID: 37659739
[TBL] [Abstract][Full Text] [Related]
15. Targeting farnesoid X receptor for liver and metabolic disorders.
Fiorucci S; Rizzo G; Donini A; Distrutti E; Santucci L
Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
[TBL] [Abstract][Full Text] [Related]
16. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
17. Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis.
Renga B; Mencarelli A; D'Amore C; Cipriani S; D'Auria MV; Sepe V; Chini MG; Monti MC; Bifulco G; Zampella A; Fiorucci S
PLoS One; 2012; 7(1):e30443. PubMed ID: 22291955
[TBL] [Abstract][Full Text] [Related]
18. The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species.
Krasowski MD; Ai N; Hagey LR; Kollitz EM; Kullman SW; Reschly EJ; Ekins S
BMC Biochem; 2011 Feb; 12():5. PubMed ID: 21291553
[TBL] [Abstract][Full Text] [Related]
19. Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats.
Ding L; Yang Y; Qu Y; Yang T; Wang K; Liu W; Xia W
Mol Med Rep; 2015 Jun; 11(6):4431-7. PubMed ID: 25634785
[TBL] [Abstract][Full Text] [Related]
20. Conicasterol E, a small heterodimer partner sparing farnesoid X receptor modulator endowed with a pregnane X receptor agonistic activity, from the marine sponge Theonella swinhoei.
Sepe V; Ummarino R; D'Auria MV; Chini MG; Bifulco G; Renga B; D'Amore C; Debitus C; Fiorucci S; Zampella A
J Med Chem; 2012 Jan; 55(1):84-93. PubMed ID: 22126372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
